Topoisomerase I inhibitors: Review and update

This publication has 79 references indexed in Scilit:

• Topoisomerase I activity and cellular response to radiation in Chinese hamster cells
  International Journal of Radiation Biology, 1996
• Irinotecan (CPT-11) and Characteristic Mucosal Changes in the Mouse Ileum and Cecum
  JNCI Journal of the National Cancer Institute, 1995
• Phase II trial of topotecan in patients with cisplatin-refractory germ cell tumors
  Investigational New Drugs, 1995
• Simultaneous Administration of CPT-11 and Fluorouracil: Alteration of the Pharmacokinetics of CPT-11 and SN-38 in Patients With Advanced Colorectal Cancer
  JNCI Journal of the National Cancer Institute, 1994
• Activity of CPT-11 (irinotecan hydrochloride), a topoisomerase I inhibitor, against human tumor colony-forming units
  Anti-Cancer Drugs, 1994
• Apoptosis Induced by DNA Topoisomerase I and II Inhibitors in Human Leukemic HL-60 Cells
  Leukemia & Lymphoma, 1994
• Phase I Clinical and Pharmacology Study of Topotecan Given Daily for 5 Consecutive Days to Patients With Advanced Solid Tumors, With Attempt at Dose Intensification Using Recombinant Granulocyte Colony-Stimulating Factor
  JNCI Journal of the National Cancer Institute, 1993
• Activity of Topotecan, a New Topoisomerase I Inhibitor, Against Human Tumor Colony-Forming Units In Vitro
  JNCI Journal of the National Cancer Institute, 1992
• HT1080/DR4: A P-Glycoprotein-Negative Human Fibrosarcoma Cell Line Exhibiting Resistance to Topoisomerase II-Reactive Drugs Despite the Presence of a Drug-Sensitive Topoisomerase II
  JNCI Journal of the National Cancer Institute, 1990
• New Natural Products in Cancer Chemotherapy
  The Journal of Clinical Pharmacology, 1990